Can-Fite Biopharma Ltd ADR
(CANF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,880 | -7,634 | -10,173 | -12,615 | -14,443 |
| Depreciation Amortization | 7 | 15 | 14 | 14 | 12 |
| Accounts receivable | N/A | N/A | N/A | N/A | 4,275 |
| Accounts payable and accrued liabilities | 223 | -300 | -188 | 967 | -1,874 |
| Other Working Capital | -267 | -943 | -1,301 | 2,430 | 2,001 |
| Other Operating Activity | 280 | 422 | 847 | -654 | -2,034 |
| Operating Cash Flow | $-7,637 | $-8,440 | $-10,801 | $-9,858 | $-12,063 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,500 | 500 | 9,511 | -14,500 | N/A |
| PPE Investments | -5 | -2 | -9 | -11 | -26 |
| Investing Cash Flow | $1,495 | $498 | $9,502 | $-14,511 | $-26 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 6,711 | 9,144 | N/A | 20,457 | 17,683 |
| Financing Cash Flow | $6,711 | $9,144 | $N/A | $20,457 | $17,683 |
| Exchange Rate Effect | -22 | 98 | -113 | 34 | -23 |
| Beginning Cash Position | 4,278 | 2,978 | 4,390 | 8,268 | 2,697 |
| End Cash Position | 4,825 | 4,278 | 2,978 | 4,390 | 8,268 |
| Net Cash Flow | $547 | $1,300 | $-1,412 | $-3,878 | $5,571 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,637 | -8,440 | -10,801 | -9,858 | -12,063 |
| Capital Expenditure | -5 | -2 | -9 | -11 | -26 |
| Free Cash Flow | -7,642 | -8,442 | -10,810 | -9,869 | -12,089 |